Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spectrum Analysis × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Thoracic 2 Genitourinary 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Other neoplasm 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1 Lymphatic Metastasis 1

Interventions

Cisplatin 515 Radiotherapy 282 pembrolizumab 275 Cetuximab 235 Radiotherapy, Intensity-Modulated 189 Docetaxel 189 Fluorouracil 166 Carboplatin 165 Paclitaxel 133 Nivolumab 118 Gemcitabine 108 Radiation 80 Magnetic Resonance Spectroscopy 77 Drug Therapy 73 toripalimab 66 Capecitabine 63 Surveys and Questionnaires 61 Surgical Procedures, Operative 59 durvalumab 54 Biopsy 53 Blood Specimen Collection 44 Cyclophosphamide 42 Chemoradiotherapy 41 camrelizumab 39 Standard of Care 37 Specimen Handling 37 Bevacizumab 37 tislelizumab 36 Erlotinib Hydrochloride 36 Radiosurgery 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03470259 2024-04-16

TARGET

University Medical Center Groningen

Phase 1 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡